Company Filing History:
Years Active: 2017
Title: Innovations of Zachary Hensel in Transcription Factor Activation
Introduction
Zachary Hensel is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of molecular biology, particularly in the area of transcription factor activation. His innovative approach has led to the development of a unique method for measuring the expression of autoregulatory molecules within living cells.
Latest Patents
Hensel holds a patent titled "Co-translational activation of a transcription factor by proteolytic cleavage and methods of use." This patent describes a method that involves the expression of an autoregulatory molecule and a marker construct in vivo. The marker is cleaved from the construct during translation, allowing for accurate measurement of autoregulatory molecule expression. The method utilizes a cleavable linker that serves as a substrate for a protease, facilitating normal folding of the autoregulatory molecule. The concentration of the measurable marker is directly related to the level of expression of the autoregulatory molecule, providing a valuable tool for researchers.
Career Highlights
Zachary Hensel is affiliated with The Johns Hopkins University, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in understanding gene regulation and cellular processes.
Collaborations
Hensel collaborates with Jie Xiao, a fellow researcher, to further explore the implications of his patented methods in various biological contexts.
Conclusion
Zachary Hensel's contributions to the field of molecular biology through his innovative patent demonstrate the importance of research in understanding complex cellular mechanisms. His work at The Johns Hopkins University continues to pave the way for future advancements in the study of autoregulatory molecules.